Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Completed 11Recruiting 8Unknown 5Terminated 4Active not recruiting 4Not yet recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Triple Negative Breast Neoplasms 1Recurrence 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Interventional × Mastectomy × Clear all
NCT03627442 2018-08-13

Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction

Invuity, Inc.

Phase NA Unknown
15 enrolled
Breast

Breast Neoplasms

NCT02953184 2017-12-29

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Jilin University

Phase 2 Unknown
160 enrolled
Breast

Breast Neoplasms

NCT02673268 2017-10-12

MARCI

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown
80 enrolled
Breast

Breast Neoplasms

NCT02464774 2015-06-08

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Sun Yat-sen University

Phase NA Unknown
464 enrolled
Breast

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

NCT01199354 2011-06-09

M-RIC

Clinique Clementville

Phase 2 Unknown
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡